CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 53 filers reported holding CYTEIR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $243,059 | +5.7% | 85,584 | -3.2% | 0.00% | – |
Q2 2023 | $229,857 | +55.4% | 88,407 | +8.8% | 0.00% | – |
Q1 2023 | $147,868 | +12.9% | 81,246 | +2.4% | 0.00% | – |
Q4 2022 | $130,917 | -65.2% | 79,344 | -59.7% | 0.00% | – |
Q3 2022 | $376,000 | -37.4% | 196,912 | -2.3% | 0.00% | – |
Q2 2022 | $601,000 | -76.0% | 201,504 | -69.7% | 0.00% | – |
Q1 2022 | $2,507,000 | -59.3% | 664,746 | +22.6% | 0.00% | – |
Q4 2021 | $6,167,000 | -10.2% | 542,422 | +38.6% | 0.00% | – |
Q3 2021 | $6,871,000 | – | 391,399 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 2,459,572 | $4,476,421 | 8.93% |
Novo Holdings A/S | 3,940,413 | $112,892,832 | 7.45% |
BML Capital Management, LLC | 3,146,296 | $5,726,259 | 4.95% |
Newtyn Management, LLC | 952,947 | $1,734,364 | 0.34% |
Aldebaran Capital, LLC | 151,239 | $275,255 | 0.28% |
Avidity Partners Management LP | 1,764,100 | $3,210,662 | 0.11% |
Marquette Asset Management, LLC | 67,990 | $123,742 | 0.03% |
TANG CAPITAL MANAGEMENT LLC | 100,000 | $182,000 | 0.03% |
RBF Capital, LLC | 117,295 | $213,477 | 0.02% |
CAAS CAPITAL MANAGEMENT LP | 150,406 | $273,739 | 0.02% |